{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:54:53Z","timestamp":1774050893445,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05759-2","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:49:05Z","timestamp":1734522545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Successful rituximab treatment in a seronegative rheumatoid arthritis patient with concurrent cold agglutinin syndrome and immune thrombocytopenia"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-7069","authenticated-orcid":false,"given":"Koji","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-8977","authenticated-orcid":false,"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5167-0715","authenticated-orcid":false,"given":"Hiroshi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5765","authenticated-orcid":false,"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"5759_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS (2023) Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med 388:529\u2013542. https:\/\/doi.org\/10.1056\/NEJMra2103726","journal-title":"N Engl J Med"},{"key":"5759_CR2","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","volume":"20","author":"A Conforti","year":"2021","unstructured":"Conforti A, Di Cola I, Pavlych V et al (2021) Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev 20:102735. https:\/\/doi.org\/10.1016\/j.autrev.2020.102735","journal-title":"Autoimmun Rev"},{"key":"5759_CR3","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","volume":"41","author":"U J\u00e4ger","year":"2020","unstructured":"J\u00e4ger U, Barcellini W, Broome CM et al (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 41:100648. https:\/\/doi.org\/10.1016\/j.blre.2019.100648","journal-title":"Blood Rev"},{"key":"5759_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/s101650170013","volume":"11","author":"N Ichikawa","year":"2001","unstructured":"Ichikawa N, Harigai M, Nakajima A et al (2001) Immune thrombocytopenic purpura associated with rheumatoid arthritis - a report of five cases and review of the literature. Mod Rheumatol 11:246\u2013250. https:\/\/doi.org\/10.3109\/s101650170013","journal-title":"Mod Rheumatol"},{"key":"5759_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMra2033982","volume":"385","author":"B Berentsen Sigbj\u00f8rn","year":"2021","unstructured":"Berentsen Sigbj\u00f8rn B Wilma (2021) Autoimmune Hemolytic Anemias. N Engl J Med 385:1407\u20131419. https:\/\/doi.org\/10.1056\/NEJMra2033982","journal-title":"N Engl J Med"},{"key":"5759_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41572-024-00566-2","volume":"10","author":"M Michel","year":"2024","unstructured":"Michel M, Crickx E, Fattizzo B, Barcellini W (2024) Autoimmune haemolytic anaemias. Nat Rev Dis Primers 10:82. https:\/\/doi.org\/10.1038\/s41572-024-00566-2","journal-title":"Nat Rev Dis Primers"},{"key":"5759_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W (2019) Immune thrombocytopenia. N Engl J Med 381:945\u2013955. https:\/\/doi.org\/10.1056\/NEJMcp1810479","journal-title":"N Engl J Med"},{"key":"5759_CR8","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1182\/blood-2003-10-3597","volume":"103","author":"S Berentsen","year":"2004","unstructured":"Berentsen S, Ulvestad E, Gjertsen BT et al (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 103:2925\u20132928. https:\/\/doi.org\/10.1182\/blood-2003-10-3597","journal-title":"Blood"},{"key":"5759_CR9","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3:3829\u20133866. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"5759_CR10","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s10067-019-04699-8","volume":"38","author":"S Tavakolpour","year":"2019","unstructured":"Tavakolpour S, Alesaeidi S, Darvishi M et al (2019) A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Clin Rheumatol 38:2977\u20132994. https:\/\/doi.org\/10.1007\/s10067-019-04699-8","journal-title":"Clin Rheumatol"},{"key":"5759_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5759_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/rheumatology\/ken076","volume":"47","author":"D Malesci","year":"2008","unstructured":"Malesci D, La Montagna G (2008) Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab. Rheumatology 47:734\u2013735. https:\/\/doi.org\/10.1093\/rheumatology\/ken076","journal-title":"Rheumatology"},{"key":"5759_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00393-010-0607-3","volume":"69","author":"P Lehmann","year":"2010","unstructured":"Lehmann P, Hartung W, Ehrenstein B et al (2010) [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease]. Z Rheumatol 69:557\u2013560. https:\/\/doi.org\/10.1007\/s00393-010-0607-3","journal-title":"Z Rheumatol"},{"key":"5759_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13019-023-02388-x","volume":"18","author":"A Mitsuishi","year":"2023","unstructured":"Mitsuishi A, Miura Y, Saeki K et al (2023) Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis. J Cardiothorac Surg 18:281. https:\/\/doi.org\/10.1186\/s13019-023-02388-x","journal-title":"J Cardiothorac Surg"},{"key":"5759_CR15","doi-asserted-by":"publisher","first-page":"e28417","DOI":"10.1097\/MD.0000000000028417","volume":"101","author":"N Zhang","year":"2022","unstructured":"Zhang N, Ji C, Bao X, Yuan C (2022) Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report: A case report. Med (Baltim) 101:e28417. https:\/\/doi.org\/10.1097\/MD.0000000000028417","journal-title":"Med (Baltim)"},{"key":"5759_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1179\/1607845412Y.0000000060","volume":"18","author":"GJ Ruiz-Arguelles","year":"2013","unstructured":"Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Vel\u00e1zquez-S\u00e1nchez-de-Cima S, Zamora-Ortiz G (2013) Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab. Hematology 18:175\u2013177. https:\/\/doi.org\/10.1179\/1607845412Y.0000000060","journal-title":"Hematology"},{"key":"5759_CR17","first-page":"1060","volume":"81","author":"AM Mu\u00f1oz","year":"2021","unstructured":"Mu\u00f1oz AM, Orozco Ni\u00f1o JA, Seehaus CM et al (2021) Evans syndrome and rheumatoid arthritis as autoimmune manifestations of large granular T-cell leukemia. Med (B Aires) 81:1060\u20131064","journal-title":"Med (B Aires)"},{"key":"5759_CR18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"5759_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","volume":"384","author":"A R\u00f6th","year":"2021","unstructured":"R\u00f6th A, Barcellini W, D\u2019Sa S et al (2021) Sutimlimab in cold agglutinin disease. N Engl J Med 384:1323\u20131334. https:\/\/doi.org\/10.1056\/NEJMoa2027760","journal-title":"N Engl J Med"},{"key":"5759_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1182\/blood.2021014955","volume":"140","author":"A R\u00f6th","year":"2022","unstructured":"R\u00f6th A, Berentsen S, Barcellini W et al (2022) Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood 140:980\u2013991. https:\/\/doi.org\/10.1182\/blood.2021014955","journal-title":"Blood"},{"key":"5759_CR21","doi-asserted-by":"publisher","first-page":"102733","DOI":"10.1016\/j.eclinm.2024.102733","volume":"74","author":"A R\u00f6th","year":"2024","unstructured":"R\u00f6th A, Berentsen S, Barcellini W et al (2024) Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B. EClinicalMedicine 74:102733. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102733","journal-title":"EClinicalMedicine"},{"key":"5759_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fimmu.2020.00590","volume":"11","author":"S Berentsen","year":"2020","unstructured":"Berentsen S (2020) New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Front Immunol 11:590. https:\/\/doi.org\/10.3389\/fimmu.2020.00590","journal-title":"Front Immunol"},{"key":"5759_CR23","doi-asserted-by":"publisher","first-page":"823563","DOI":"10.1155\/2015\/823563","volume":"2015","author":"K Honne","year":"2015","unstructured":"Honne K, Nagashima T, Iwamoto M et al (2015) Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis. Case Rep Rheumatol 2015:823563. https:\/\/doi.org\/10.1155\/2015\/823563","journal-title":"Case Rep Rheumatol"},{"key":"5759_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12185-019-02790-z","volume":"111","author":"H Kashiwagi","year":"2020","unstructured":"Kashiwagi H, Kuwana M, Hato T et al (2020) Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol 111:329\u2013351. https:\/\/doi.org\/10.1007\/s12185-019-02790-z","journal-title":"Int J Hematol"},{"key":"5759_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s100670200136","volume":"21","author":"C Ustun","year":"2002","unstructured":"Ustun C, Kallab A, Loebl D et al (2002) Rheumatoid arthritis and immune thrombocytopenia: a report of two cases. Clin Rheumatol 21:543\u2013544. https:\/\/doi.org\/10.1007\/s100670200136","journal-title":"Clin Rheumatol"},{"key":"5759_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10067-005-1113-x","volume":"24","author":"T Horino","year":"2005","unstructured":"Horino T, Sasaoka A, Takao T et al (2005) Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report. Clin Rheumatol 24:641\u2013644. https:\/\/doi.org\/10.1007\/s10067-005-1113-x","journal-title":"Clin Rheumatol"},{"key":"5759_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","volume":"18","author":"HU Scherer","year":"2022","unstructured":"Scherer HU, van der Woude D, Toes REM (2022) From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat Rev Rheumatol 18:371\u2013383. https:\/\/doi.org\/10.1038\/s41584-022-00786-4","journal-title":"Nat Rev Rheumatol"},{"key":"5759_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","volume":"72","author":"JD Isaacs","year":"2013","unstructured":"Isaacs JD, Cohen SB, Emery P et al (2013) Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 72:329\u2013336. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201117","journal-title":"Ann Rheum Dis"},{"key":"5759_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","volume":"87","author":"RS Evans","year":"1951","unstructured":"Evans RS, Takahashi K, Duane RT et al (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 87:48\u201365. https:\/\/doi.org\/10.1001\/archinte.1951.03810010058005","journal-title":"AMA Arch Intern Med"},{"key":"5759_CR30","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1182\/bloodadvances.2021005610","volume":"5","author":"B Fattizzo","year":"2021","unstructured":"Fattizzo B, Michel M, Giannotta JA et al (2021) Evans syndrome in adults: an observational multicenter study. Blood Adv 5:5468\u20135478. https:\/\/doi.org\/10.1182\/bloodadvances.2021005610","journal-title":"Blood Adv"},{"key":"5759_CR31","doi-asserted-by":"publisher","unstructured":"Audia S, Grienay N, Mounier M et al (2020) Evans\u2019 Syndrome: From Diagnosis to Treatment. J Clin Med Res 9. https:\/\/doi.org\/10.3390\/jcm9123851","DOI":"10.3390\/jcm9123851"},{"key":"5759_CR32","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1182\/bloodadvances.2021006864","volume":"7","author":"CM Broome","year":"2023","unstructured":"Broome CM, R\u00f6th A, Kuter DJ et al (2023) Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia. Blood Adv 7:987\u2013996. https:\/\/doi.org\/10.1182\/bloodadvances.2021006864","journal-title":"Blood Adv"},{"key":"5759_CR33","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.1800998","volume":"202","author":"PA Nikitin","year":"2019","unstructured":"Nikitin PA, Rose EL, Byun TS et al (2019) C1s inhibition by BIVV009 (Sutimlimab) prevents complement-enhanced activation of autoimmune human B cells in vitro. J Immunol 202:1200\u20131209. https:\/\/doi.org\/10.4049\/jimmunol.1800998","journal-title":"J Immunol"},{"key":"5759_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-016-0951-z","volume":"18","author":"K Chatzidionysiou","year":"2016","unstructured":"Chatzidionysiou K, Lie E, Nasonov E et al (2016) Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. Arthritis Res Ther 18:50. https:\/\/doi.org\/10.1186\/s13075-016-0951-z","journal-title":"Arthritis Res Ther"},{"key":"5759_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3899\/jrheum.160460","volume":"44","author":"K Chatzidionysiou","year":"2017","unstructured":"Chatzidionysiou K, Lie E, Lukina G et al (2017) Rituximab retreatment in rheumatoid arthritis in a real-life cohort: Data from the CERERRA collaboration. J Rheumatol 44:162\u2013169. https:\/\/doi.org\/10.3899\/jrheum.160460","journal-title":"J Rheumatol"},{"key":"5759_CR36","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1016\/S2665-9913(20)30033-3","volume":"2","author":"L Garcia-Montoya","year":"2020","unstructured":"Garcia-Montoya L, Villota-Eraso C, Yusof MYM et al (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. Lancet Rheumatol 2:e497\u2013e509. https:\/\/doi.org\/10.1016\/S2665-9913(20)30033-3","journal-title":"Lancet Rheumatol"},{"key":"5759_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1182\/blood.2019003809","volume":"137","author":"S Berentsen","year":"2021","unstructured":"Berentsen S (2021) How I treat cold agglutinin disease. Blood 137:1295\u20131303. https:\/\/doi.org\/10.1182\/blood.2019003809","journal-title":"Blood"},{"key":"5759_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/bjh.16672","volume":"191","author":"E Tj\u00f8nnfjord","year":"2020","unstructured":"Tj\u00f8nnfjord E, Holme PA, Darne B et al (2020) Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study. Br J Haematol 191:460\u2013465. https:\/\/doi.org\/10.1111\/bjh.16672","journal-title":"Br J Haematol"},{"key":"5759_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood.2020005674","volume":"136","author":"S Berentsen","year":"2020","unstructured":"Berentsen S, Barcellini W, D\u2019Sa S et al (2020) Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 136:480\u2013488. https:\/\/doi.org\/10.1182\/blood.2020005674","journal-title":"Blood"},{"key":"5759_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ajh.21512","volume":"84","author":"A Hasan","year":"2009","unstructured":"Hasan A, Michel M, Patel V et al (2009) Repeated courses of rituximab in chronic ITP: Three different regimens. Am J Hematol 84:661\u2013665. https:\/\/doi.org\/10.1002\/ajh.21512","journal-title":"Am J Hematol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05759-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05759-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05759-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:39:49Z","timestamp":1737700789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05759-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["5759"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05759-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors obtained written informed consent from the patient for his medical information to be published by this report. Patient consent form is retained by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"2"}}